Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.72 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.72 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.72 |
| ▸ | PGR | P06401 | 1/20 | 0.72 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.65 |
| ▸ | OXER1 | Q8TDS5 | 5/20 | 0.65 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.65 |
| ▸ | F7 | P08709 | 3/20 | 0.65 |
| ▸ | F3 | P13726 | 3/20 | 0.65 |
| ▸ | PPARG | P37231 | 3/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | PPARD | Q03181 | 2/20 | 0.65 |
| ▸ | PPARA | Q07869 | 2/20 | 0.65 |
| ▸ | RXRA | P19793 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13129422 | 1.00 | ADORA3 (0.72) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL983231 | 1.00 | ADORA3 (0.72) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL13921384 | 1.00 | ADORA3 (0.72) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL16995167 | 1.00 | ADORA3 (0.72) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL983229 | 1.00 | ADORA3 (0.72) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL31720876 | 0.98 | ADORA3 (0.70) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL7712920 | 0.95 | ALDH1A1 (0.71) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6930194 | 0.95 | ALDH1A1 (0.71) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL14242243 | 0.95 | ALDH1A1 (0.71) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL6930187 | 0.95 | ALDH1A1 (0.71) | ADORA3NR1I2PTGS2PGRPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12596127-B2 | Prediction of the content of omega-3 polyunsaturated fatty acids in the retina by measuring 7 cholesterol ester molecules | Universite de Bordeaux (FR) | 2026-04-07 | — | — | US | disclosed |
| US-20250340910-A1 | FATTY ACID PRODUCTION IN ESCHERICHIA COLI | UNIV PUERTO RICO (US) | 2025-11-06 | — | — | US | disclosed |
| WO-2023279749-A1 | APPLICATION OF ULTRA-FAST GAS-PHASE ELECTRONIC NOSE IN DETECTING FATTY ACIDS | 佳禾食品工业股份有限公司 | 2023-01-12 | — | — | WO | disclosed |
| US-20220373567-A1 | PREDICTION OF THE CONTENT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE RETINA BY MEASURING 7 CHOLESTEROL ESTER MOLECULES | Universite de Bordeaux (FR) | 2022-11-24 | — | — | US | disclosed |
| US-11292807-B2 | Molecules from seaweeds with anti-cancer activity | OCEANS LTD. (CA) | 2022-04-05 | — | — | US | disclosed |
| EP-3405461-B1 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | OCEANS LTD (CA) | 2021-11-24 | — | — | EP | disclosed |
| US-20210323940-A1 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | OCEANS LTD. (CA) | 2021-10-21 | — | — | US | disclosed |
| US-11091715-B2 | Fuel compositions based on binders from birch bark | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-08-17 | — | — | US | disclosed |
| WO-2021058914-A1 | PREDICTION OF THE CONTENT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE RETINA BY MEASURING 7 CHOLESTEROL ESTER MOLECULES | Universite de Bordeaux (FR) | 2021-04-01 | — | — | WO | disclosed |
| US-20210087485-A1 | BIODIESEL FROM KARAYA OIL | UNIV KING ABDULLAH SCI & TECH (SA) | 2021-03-25 | — | — | US | disclosed |
| US-10822322-B2 | Molecule with anti-cancer activity | OCEANS LTD. (CA) | 2020-11-03 | — | — | US | disclosed |
| US-20200291054-A1 | MOLECULES FROM SEAWEEDS WITH ANTI-CANCER ACTIVITY | OCEANS LTD (CA) | 2020-09-17 | — | — | US | disclosed |
| CN-111650286-A | Method for detecting medium-long chain fatty acid in human serum based on gas chromatography-mass spectrometry | 上海中科新生命生物科技有限公司 | 2020-09-11 | — | — | CN | disclosed |
| US-20190316052-A1 | FUEL COMPOSITIONS BASED ON BINDERS FROM BIRCH BARK | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2019-10-17 | — | — | US | disclosed |
| US-20190185501-A1 | NEW MOLECULES FROM SEAWEEDS WITH ANTI-CANCER ACTIVITY | OCEANS LTD. (CA) | 2019-06-20 | — | — | US | disclosed |
| US-20190040032-A1 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | OCEANS LTD. (CA) | 2019-02-07 | — | — | US | disclosed |
| WO-2011106867-A1 | TUNICATE EXTRACTS AND USES THEREOF IN ANTI-ALLERGY APPLICATIONS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-09-09 | — | — | WO | disclosed |
| US-7873481-B2 | System and method for analyzing a sample using chromatography coupled mass spectrometry | METANOMICS GMBH (DE) | 2011-01-18 | — | — | US | disclosed |
| US-20080234945-A1 | Means and Methods for Analyzing a Sample by Means of Chromatography-Mass Spectrometry | METANOMICS GMBH (DE) | 2008-09-25 | — | — | US | disclosed |
| US-6399105-B1 | LIPOXYGENASE INHIBITORS FOR INFLAMMATORY AUTOIMMUNE DISEASES | COLLIN PETER DONALD (US) | 2002-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040032-A1 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | MKI67, PCLAF, DDX21 | ADORA3 4302/4885NR1I2 2342/4885PTGS2 360/4885 |
| US-20200291054-A1 | MOLECULES FROM SEAWEEDS WITH ANTI-CANCER ACTIVITY | FASN, ELOVL1, ELOVL5 | ADORA3 1365/4885NR1I2 640/4885PTGS2 32/4885 |
| US-11292807-B2 | Molecules from seaweeds with anti-cancer activity | FASN, ELOVL1, ELOVL5 | ADORA3 1365/4885NR1I2 640/4885PTGS2 32/4885 |
| US-12596127-B2 | Prediction of the content of omega-3 polyunsaturated fatty acids in the retina by measuring 7 cholesterol ester molecules | ELOVL3, STARD3, ELOVL1 | ADORA3 559/4885NR1I2 1703/4885PTGS2 983/4885 |
| US-10822322-B2 | Molecule with anti-cancer activity | MKI67, PCLAF, NOLC1 | ADORA3 4073/4885NR1I2 2174/4885PTGS2 236/4885 |
| US-20190185501-A1 | NEW MOLECULES FROM SEAWEEDS WITH ANTI-CANCER ACTIVITY | ELOVL1, FASN, ELOVL5 | ADORA3 1756/4885NR1I2 907/4885PTGS2 35/4885 |
| US-20210323940-A1 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | GRAMD1A, CNR2, CNR1 | ADORA3 3443/4885NR1I2 1109/4885PTGS2 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.